import type { BlogArticle } from '../blog-types';

export const article: BlogArticle = {
  slug: "peptide-sciences-shutdown-what-researchers-need-now",
  title: "Peptide Sciences Shut Down: What Researchers Need to Know Now",
  description:
    "Peptide Sciences went dark in early 2026, leaving researchers mid-study without a supplier. This article covers the closure timeline, what it means for ongoing protocols, and the non-negotiable criteria for qualifying a new research peptide source.",
  category: "Industry",
  readMinutes: 9,
  publishedAt: "2026-06-18",
  ogImage: "/og-image.jpg",
  body: [
    {
      type: "paragraph",
      text: "In early 2026, Peptide Sciences — a supplier that had served the North American research peptide market for over a decade — ceased operations without formal notice. Orders were left unfulfilled, customer support went silent, and a vendor that an estimated 70,000+ monthly users had come to rely on simply disappeared. For researchers mid-protocol, the disruption was immediate.",
    },
    {
      type: "paragraph",
      text: "This article is a practical reference for what happened, what it means for ongoing research workflows, and the rigorous criteria any replacement supplier must meet before being used in a serious research context.",
    },
    {
      type: "heading",
      text: "What Happened to Peptide Sciences",
    },
    {
      type: "paragraph",
      text: "Peptide Sciences was, by most measures, one of the more professionally operated vendors in a market not known for consistency. It offered HPLC-tested products, reasonable documentation, and broad catalog coverage. The sudden closure in 2026 fits a pattern the research peptide industry has seen before: abrupt shutdowns following regulatory pressure, payment processing restrictions, supply chain failures, or operational insolvency.",
    },
    {
      type: "paragraph",
      text: "No official explanation was provided. For researchers, the practical consequence is the same regardless of cause: an established source with familiar batch quality is gone, and a replacement must be qualified before any ongoing protocols can continue with confidence.",
    },
    {
      type: "callout",
      text: "Vendor disruptions like this underscore why researchers should maintain documentation of every batch received — lot numbers, COA data, storage conditions — not just for data integrity, but to understand any batch-to-batch continuity issues when transitioning to a new source.",
    },
    {
      type: "heading",
      text: "The Qualification Problem: Why Most Replacements Fall Short",
    },
    {
      type: "paragraph",
      text: "The research peptide market suffers from a persistent quality dispersion problem. Synthetic peptide manufacturing is increasingly performed by contract manufacturers with highly variable quality assurance practices. When a large, familiar vendor exits the market, demand is rapidly captured by lower-tier operators — many of whom market with similar professional language but lack the testing infrastructure to support it.",
    },
    {
      type: "paragraph",
      text: "A 2022 independent analysis of commercial peptide products found measurable discrepancies between claimed and actual purity in a substantial fraction of sampled products. Sequence misidentification, purity inflation, and contamination from unreacted synthesis reagents have all been documented. In any research context where compound identity and purity directly affect experimental validity, this matters.",
    },
    {
      type: "heading",
      text: "Non-Negotiable Qualification Criteria",
    },
    {
      type: "subheading",
      text: "1. Batch-Specific HPLC Chromatograms",
    },
    {
      type: "paragraph",
      text: "High-Performance Liquid Chromatography (HPLC) remains the industry standard for peptide purity verification. A research-grade supplier must provide the actual chromatogram — not simply a stated percentage — for the specific batch being supplied. Minimum acceptable purity for most research applications is ≥98%. Generic or non-batch-specific HPLC documents are a disqualifying finding.",
    },
    {
      type: "subheading",
      text: "2. Mass Spectrometry Identity Confirmation",
    },
    {
      type: "paragraph",
      text: "HPLC confirms purity; it does not confirm identity. A peptide can return a high HPLC purity score and still be the wrong compound. Mass spectrometry (MS) — ideally LC-MS — provides molecular weight confirmation that verifies the correct sequence has been synthesized. Both tests should be batch-specific and third-party verified.",
    },
    {
      type: "subheading",
      text: "3. LAL Endotoxin Testing",
    },
    {
      type: "paragraph",
      text: "The Limulus Amebocyte Lysate (LAL) test detects bacterial endotoxin (lipopolysaccharide) contamination. Endotoxin is a common synthesis contaminant that can trigger inflammatory responses in cell culture and animal models, directly confounding experimental results. LAL testing is essential for any compound intended for in vitro or in vivo research use.",
    },
    {
      type: "subheading",
      text: "4. Cold-Chain Shipping Infrastructure",
    },
    {
      type: "paragraph",
      text: "Peptides are temperature-sensitive. Exposure to heat, moisture, or freeze-thaw cycling during shipping degrades compound integrity — often invisibly. A qualified supplier must demonstrate cold-chain handling: lyophilized format, appropriate cold packs or dry ice for transit, and clear storage guidance on receipt.",
    },
    {
      type: "subheading",
      text: "5. Regulatory Compliance in Labeling",
    },
    {
      type: "paragraph",
      text: "All research peptides must be labeled explicitly: \"For Research Use Only. Not for human use.\" Suppliers who omit this language, use wellness-forward marketing, or imply clinical applications create regulatory and liability exposure for the researchers who use their products. Compliance posture is a signal of operational discipline across the business.",
    },
    {
      type: "heading",
      text: "Transitioning Mid-Protocol: A Practical Checklist",
    },
    {
      type: "paragraph",
      text: "For researchers who were mid-study when Peptide Sciences closed, transitioning to a new supplier requires additional diligence to preserve data integrity.",
    },
    {
      type: "list",
      items: [
        "Document all lot numbers, COA data, and storage history for the Peptide Sciences batches used in your study",
        "Treat any new supplier batch as a new variable — consider whether mid-study transition affects your data interpretation",
        "Request and review the new supplier's COA before ordering — do not rely on product page claims alone",
        "Verify HPLC purity, MS identity, and LAL test results for your specific compound from the prospective supplier",
        "Confirm shipping method — request cold-pack or dry ice inclusion for temperature-sensitive compounds",
        "For long-running studies, establish a secondary qualified supplier to reduce single-source risk going forward",
      ],
    },
    {
      type: "heading",
      text: "What Nexphoria Provides",
    },
    {
      type: "paragraph",
      text: "Nexphoria was built around the documentation and quality standards that the closure of vendors like Peptide Sciences made newly visible. Every product in the catalog ships with batch-specific HPLC chromatograms, mass spectrometry identity confirmation, LAL endotoxin test results, and a full Certificate of Analysis accessible at the point of purchase — not on request.",
    },
    {
      type: "paragraph",
      text: "Products are lyophilized and handled with cold-chain logistics from synthesis through delivery. Labeling is research-use-only, with no clinical language or wellness marketing. The catalog is designed for researchers who treat supplier qualification with the same rigor they bring to their protocols.",
    },
    {
      type: "divider",
    },
    {
      type: "disclaimer",
      text: "All Nexphoria products are sold exclusively for in vitro and pre-clinical research use. They are not intended for human consumption, diagnostic use, or therapeutic application. Nothing in this article constitutes medical or legal advice.",
    },
  ],
};
